Clinical Trials Browser

Phase 4 × Cannabidiol × 90 days × Clear all

NCT05044819 2026-06-01

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Phase 4 Active not recruiting

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05864846 2026-04-27

EpiCom

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis